Abstract
Scientists have long considered genetics to be the key mechanism that alters gene expression because of exposure to the environment and toxic substances (toxicants). Recently, epigenetic mechanisms have emerged as an alternative explanation for alterations in gene expression resulting from such exposure. The fact that certain toxic substances that contribute to tumor development do not induce mutations probably results from underlying epigenetic mechanisms. The field of toxicoepigenomics emerged from the combination of epigenetics and classical toxicology. High-throughput technologies now enable evaluation of altered epigenomic profiling in response to toxins and environmental pollutants. Furthermore, differences in the epigenomic backgrounds of individuals may explain why, although whole populations are exposed to toxicants, only a few people in a population develop cancer. Metals in the environment and toxic substances not only alter DNA methylation patterns and histone modifications but also affect enzymes involved in posttranslational modifications of proteins and epigenetic regulation, and thereby contribute to carcinogenesis. This article describes different toxic substances and environmental pollutants that alter epigenetic profiling and discusses how this information can be used in screening populations at high risk of developing cancer. Research opportunities and challengers in the field also are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- DNMTs:
-
DNA methyltransferases
- EWAS:
-
Epigenome-wide association studies
- GWAS:
-
Genome-wide association studies
- HAT:
-
Histone acetyltransferase
- HDACS:
-
Histone deacetylases
- LINE:
-
Long integrated nuclear element
- MDBPs:
-
Methylated DNA-binding proteins
- miRNA:
-
microRNA
- PFOS:
-
Perfluorooctane sulfonate
- SINE:
-
Small integrated nuclear element
References
Legler J (2010) Epigenetics: an emerging field in environmental toxicology. Integr Environ Assess Manag 6:314–315
Luteijn MJ, Ketting RF (2013) PIWI-interacting RNAs: from generation to transgenerational epigenetics. Nat Rev Genet 14:523–534
Smirnova L, Sittka A, Luch A (2012) On the role of low-dose effects and epigenetics in toxicology. EXS 101:499–550
Hu J, Ma H, Zhang W, Yu Z, Sheng G, Fu J (2014) Effects of benzene and its metabolites on global DNA methylation in human normal hepatic l02 cells. Environ Toxicol 29:108–116
Xing C, Chen Q, Li G, Zhang L, Zheng M, Zou Z, Hou L, Wang QF, Liu X, Guo X (2013) Microsomal epoxide hydrolase (EPHX1) polymorphisms are associated with aberrant promoter methylation of ERCC3 and hematotoxicity in benzene-exposed workers. Environ Mol Mutagen 54:397–405
Seow WJ, Pesatori AC, Dimont E, Farmer PB, Albetti B, Ettinger AS, Bollati V, Bolognesi C, Roggieri P, Panev TI, Georgieva T, Merlo DF, Bertazzi PA, Baccarelli AA (2012) Urinary benzene biomarkers and DNA methylation in Bulgarian petrochemical workers: study findings and comparison of linear and beta regression models. PLoS One 7:e50471
Fustinoni S, Rossella F, Polledri E, Bollati V, Campo L, Byun HM, Agnello L, Consonni D, Pesatori AC, Baccarelli A, Bertazzi PA (2012) Global DNA methylation and low-level exposure to benzene. Med Lav 103:84–95
Ren X, McHale CM, Skibola CF, Smith AH, Smith MT, Zhang L (2011) An emerging role for epigenetic dysregulation in arsenic toxicity and carcinogenesis. Environ Health Perspect 119:11–19
Verma M (2012) Epigenome-Wide Association Studies (EWAS) in Cancer. Curr Genomics 13:308–313
Berghof TV, Parmentier HK, Lammers A (2013) Transgenerational epigenetic effects on innate immunity in broilers: an underestimated field to be explored? Poult Sci 92:2904–2913
Anderson GD, Acheampong AA, Wilensky AJ, Levy RH (1992) Effect of valproate dose on formation of hepatotoxic metabolites. Epilepsia 33:736–742
Su S, Jin Y, Zhang W, Yang L, Shen Y, Cao Y, Tong J (2006) Aberrant promoter methylation of p16(INK4a) and O(6)-methylguanine-DNA methyltransferase genes in workers at a Chinese uranium mine. J Occup Health 48:261–266
Verma M, Rogers S, Divi RL, Scully SD, Nelson S, Su LJ, Ross S, Pilch S, Winn DM, Khoury MJ (2014) Epigenetic research in cancer epidemiology: trends, opportunities, and challenges. Cancer Epidemiol Biomarkers Prev 23:223–233
Verma M, Khoury MJ, Ioannidis JP (2013) Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling. Cancer Epidemiol Biomarkers Prev 22:189–200
Verma M (2012) Epigenetic biomarkers in cancer epidemiology. Methods Mol Biol 863:467–480
Deng G, Chen A, Hong J, Chae HS, Kim YS (1999) Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res 59:2029–2033
Herceg Z, Ushijima T (2010) Epigenetics is a fascinating field of modern biology. Preface. Adv Genet 71:xi–xii
Herceg Z, Ushijima T (2010) Introduction: epigenetics and cancer. Adv Genet 70:1–23
Herceg Z (2007) Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors. Mutagenesis 22:91–103
Larsen F, Gundersen G, Lopez R, Prydz H (1992) CpG islands as gene markers in the human genome. Genomics 13:1095–1107
Jawert F, Hasseus B, Kjeller G, Magnusson B, Sand L, Larsson L (2013) Loss of 5-hydroxymethylcytosine and TET2 in oral squamous cell carcinoma. Anticancer Res 33:4325–4328
Yang Q, Wu K, Ji M, Jin W, He N, Shi B, Hou P (2013) Decreased 5-hydroxymethylcytosine (5-hmC) is an independent poor prognostic factor in gastric cancer patients. J Biomed Nanotechnol 9:1607–1616
Verma M (2013) Cancer control and prevention: nutrition and epigenetics. Curr Opin Clin Nutr Metab Care 16:376–384
Khare S, Verma M (2012) Epigenetics of colon cancer. Methods Mol Biol 863:177–185
Mishra A, Verma M (2012) Epigenetics of solid cancer stem cells. Methods Mol Biol 863:15–31
Kumar D, Verma M (2009) Methods in cancer epigenetics and epidemiology. Methods Mol Biol 471:273–288
Inamochi Y, Mochizuki K, Goda T (2014) Histone code of genes induced by co-treatment with a glucocorticoid hormone agonist and a p44/42 MAPK inhibitor in human small intestinal Caco-2 cells. Biochim Biophys Acta 1840:693–700
Lau PN, Cheung P (2011) Histone code pathway involving H3 S28 phosphorylation and K27 acetylation activates transcription and antagonizes polycomb silencing. Proc Natl Acad Sci U S A 108:2801–2806
Garske AL, Craciun G, Denu JM (2008) A combinatorial H4 tail library for exploring the histone code. Biochemistry 47:8094–8102
Lukas J, Bartek J (2008) DNA damage: a histone-code mediator leaves the stage. Nat Struct Mol Biol 15:430–432
Crea F (2012) Histone code, human growth and cancer. Oncotarget 3:1–2
Szyf M (2011) The early life social environment and DNA methylation: DNA methylation mediating the long-term impact of social environments early in life. Epigenetics 6:971–978
Szyf M (2011) DNA methylation, the early-life social environment and behavioral disorders. J Neurodev Disord 3:238–249
Szyf M (2011) The implications of DNA methylation for toxicology: toward toxicomethylomics, the toxicology of DNA methylation. Toxicol Sci 120:235–255
Szyf M (2009) Epigenetics, DNA methylation, and chromatin modifying drugs. Annu Rev Pharmacol Toxicol 49:243–263
Arita A, Munoz A, Chervona Y, Niu J, Qu Q, Zhao N, Ruan Y, Kiok K, Kluz T, Sun H, Clancy HA, Shamy M, Costa M (2013) Gene expression profiles in peripheral blood mononuclear cells of Chinese nickel refinery workers with high exposures to nickel and control subjects. Cancer Epidemiol Biomarkers Prev 22:261–269
Chervona Y, Hall MN, Arita A, Wu F, Sun H, Tseng HC, Ali E, Uddin MN, Liu X, Zoroddu MA, Gamble MV, Costa M (2012) Associations between arsenic exposure and global posttranslational histone modifications among adults in Bangladesh. Cancer Epidemiol Biomarkers Prev 21:2252–2260
Chervona Y, Costa M (2012) Histone modifications and cancer: biomarkers of prognosis? Am J Cancer Res 2:589–597
Chervona Y, Costa M (2012) The control of histone methylation and gene expression by oxidative stress, hypoxia, and metals. Free Radic Biol Med 53:1041–1047
Arita A, Shamy MY, Chervona Y, Clancy HA, Sun H, Hall MN, Qu Q, Gamble MV, Costa M (2012) The effect of exposure to carcinogenic metals on histone tail modifications and gene expression in human subjects. J Trace Elem Med Biol 26:174–178
Chervona Y, Arita A, Costa M (2012) Carcinogenic metals and the epigenome: understanding the effect of nickel, arsenic, and chromium. Metallomics 4:619–627
Arita A, Niu J, Qu Q, Zhao N, Ruan Y, Nadas A, Chervona Y, Wu F, Sun H, Hayes RB, Costa M (2012) Global levels of histone modifications in peripheral blood mononuclear cells of subjects with exposure to nickel. Environ Health Perspect 120:198–203
Anway MD, Cupp AS, Uzumcu M, Skinner MK (2005) Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308:1466–1469
Li Y, Saldanha SN, Tollefsbol TO (2014) Impact of epigenetic dietary compounds on transgenerational prevention of human diseases. AAPS J 16:27–36
Brasset E, Chambeyron S (2013) Epigenetics and transgenerational inheritance. Genome Biol 14:306
Skinner MK (2011) Role of epigenetics in developmental biology and transgenerational inheritance. Birth Defects Res C Embryo Today 93:51–55
Watson RE, Goodman JI (2002) Epigenetics and DNA methylation come of age in toxicology. Toxicol Sci 67:11–16
Arita A, Costa M (2009) Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium. Metallomics 1:222–228
Ren X, Aleshin M, Jo WJ, Dills R, Kalman DA, Vulpe CD, Smith MT, Zhang L (2011) Involvement of N-6 adenine-specific DNA methyltransferase 1 (N6AMT1) in arsenic biomethylation and its role in arsenic-induced toxicity. Environ Health Perspect 119:771–777
Sturchio E, Colombo T, Boccia P, Carucci N, Meconi C, Minoia C, Macino G (2013) Arsenic exposure triggers a shift in microRNA expression. Sci Total Environ 472C:672–680
Cao Y, Yu SL, Wang Y, Guo GY, Ding Q, An RH (2011) MicroRNA-dependent regulation of PTEN after arsenic trioxide treatment in bladder cancer cell line T24. Tumour Biol 32:179–188
Kojima C, Ramirez DC, Tokar EJ, Himeno S, Drobna Z, Styblo M, Mason RP, Waalkes MP (2009) Requirement of arsenic biomethylation for oxidative DNA damage. J Natl Cancer Inst 101:1670–1681
Lin HJ, Sung TI, Chen CY, Guo HR (2013) Arsenic levels in drinking water and mortality of liver cancer in Taiwan. J Hazard Mater 262:1132–1138
Liu J, Waalkes MP (2008) Liver is a target of arsenic carcinogenesis. Toxicol Sci 105:24–32
Kile ML, Ronnenberg AG (2008) Can folate intake reduce arsenic toxicity? Nutr Rev 66:349–353
Ji Z, Zhang L, Peng V, Ren X, McHale CM, Smith MT (2010) A comparison of the cytogenetic alterations and global DNA hypomethylation induced by the benzene metabolite, hydroquinone, with those induced by melphalan and etoposide. Leukemia 24:986–991
Bollati V, Baccarelli A, Hou L, Bonzini M, Fustinoni S, Cavallo D, Byun HM, Jiang J, Marinelli B, Pesatori AC, Bertazzi PA, Yang AS (2007) Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res 67:876–880
Sanders AP, Smeester L, Rojas D, Debussycher T, Wu MC, Wright FA, Zhou YH, Laine JE, Rager JE, Swamy GK, Ashley-Koch A, Lynn Miranda M, Fry RC (2014) Cadmium exposure and the epigenome: exposure-associated patterns of DNA methylation in leukocytes from mother-baby pairs. Epigenetics 9:212–221
Kondo K, Takahashi Y, Hirose Y, Nagao T, Tsuyuguchi M, Hashimoto M, Ochiai A, Monden Y, Tangoku A (2006) The reduced expression and aberrant methylation of p16(INK4a) in chromate workers with lung cancer. Lung Cancer 53:295–302
Takahashi Y, Kondo K, Hirose T, Nakagawa H, Tsuyuguchi M, Hashimoto M, Sano T, Ochiai A, Monden Y (2005) Microsatellite instability and protein expression of the DNA mismatch repair gene, hMLH1, of lung cancer in chromate-exposed workers. Mol Carcinog 42:150–158
Kippler M, Engstrom K, Mlakar SJ, Bottai M, Ahmed S, Hossain MB, Raqib R, Vahter M, Broberg K (2013) Sex-specific effects of early life cadmium exposure on DNA methylation and implications for birth weight. Epigenetics 8:494–503
Zhou ZH, Lei YX, Wang CX (2012) Analysis of aberrant methylation in DNA repair genes during malignant transformation of human bronchial epithelial cells induced by cadmium. Toxicol Sci 125:412–417
Ali AH, Kondo K, Namura T, Senba Y, Takizawa H, Nakagawa Y, Toba H, Kenzaki K, Sakiyama S, Tangoku A (2011) Aberrant DNA methylation of some tumor suppressor genes in lung cancers from workers with chromate exposure. Mol Carcinog 50:89–99
Boellmann F, Zhang L, Clewell HJ, Schroth GP, Kenyon EM, Andersen ME, Thomas RS (2010) Genome-wide analysis of DNA methylation and gene expression changes in the mouse lung following subchronic arsenate exposure. Toxicol Sci 117:404–417
Lee YW, Klein CB, Kargacin B, Salnikow K, Kitahara J, Dowjat K, Zhitkovich A, Christie NT, Costa M (1995) Carcinogenic nickel silences gene expression by chromatin condensation and DNA methylation: a new model for epigenetic carcinogens. Mol Cell Biol 15:2547–2557
Yan Y, Kluz T, Zhang P, Chen HB, Costa M (2003) Analysis of specific lysine histone H3 and H4 acetylation and methylation status in clones of cells with a gene silenced by nickel exposure. Toxicol Appl Pharmacol 190:272–277
Zhang J, Li M, Wu Y, Fan Y, Zhou Y, Tan L, Shao Z, Shi H (2011) Methylation of RAR-beta2, RASSF1A, and CDKN2A genes induced by nickel subsulfide and nickel-carcinogenesis in rats. Biomed Environ Sci 24:163–171
Lee YW, Broday L, Costa M (1998) Effects of nickel on DNA methyltransferase activity and genomic DNA methylation levels. Mutat Res 415:213–218
Zhou X, Li Q, Arita A, Sun H, Costa M (2009) Effects of nickel, chromate, and arsenite on histone 3 lysine methylation. Toxicol Appl Pharmacol 236:78–84
Costa M, Davidson TL, Chen H, Ke Q, Zhang P, Yan Y, Huang C, Kluz T (2005) Nickel carcinogenesis: epigenetics and hypoxia signaling. Mutat Res 592:79–88
Wan YJ, Li YY, Xia W, Chen J, Lv ZQ, Zeng HC, Zhang L, Yang WJ, Chen T, Lin Y, Wei J, Xu SQ (2010) Alterations in tumor biomarker GSTP gene methylation patterns induced by prenatal exposure to PFOS. Toxicology 274:57–64
Watkins DJ, Wellenius GA, Butler RA, Bartell SM, Fletcher T, Kelsey KT (2014) Associations between serum perfluoroalkyl acids and LINE-1 DNA methylation. Environ Int 63:71–76
Jain RB (2013) Effect of pregnancy on the levels of selected perfluoroalkyl compounds for females aged 17–39 years: data from National Health and Nutrition Examination Survey 2003–2008. J Toxicol Environ Health A 76:409–421
Miller AC, Stewart M, Rivas R (2009) DNA methylation during depleted uranium-induced leukemia. Biochimie 91:1328–1330
Hanna CW, Bloom MS, Robinson WP, Kim D, Parsons PJ, vom Saal FS, Taylor JA, Steuerwald AJ, Fujimoto VY (2012) DNA methylation changes in whole blood is associated with exposure to the environmental contaminants, mercury, lead, cadmium and bisphenol A, in women undergoing ovarian stimulation for IVF. Hum Reprod 27:1401–1410
Brouwer KL, Hall ES, Pollack GM (1993) Protein binding and hepatobiliary distribution of valproic acid and valproate glucuronide in rats. Biochem Pharmacol 45:735–742
Chiou WL (1978) Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level–time curve. J Pharmacokinet Biopharm 6:539–546
Cotariu D, Evans S, Zaidman JL, Marcus O (1990) Early changes in hepatic redox homeostasis following treatment with a single dose of valproic acid. Biochem Pharmacol 40:589–593
Pansoy A, Ahmed S, Valen E, Sandelin A, Matthews J (2010) 3-methylcholanthrene induces differential recruitment of aryl hydrocarbon receptor to human promoters. Toxicol Sci 117:90–100
Acknowledgements
We are thankful to Joanne Brodsky of The Scientific Consulting Group, Inc., for reading the manuscript and providing suggestions.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Verma, M. (2015). Toxicoepigenomics and Cancer: Implications for Screening. In: Verma, M. (eds) Cancer Epigenetics. Methods in Molecular Biology, vol 1238. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1804-1_19
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1804-1_19
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1803-4
Online ISBN: 978-1-4939-1804-1
eBook Packages: Springer Protocols